InsidersTradesSigma
Track the BioPharma Credit PLC share price and the full insider trade history of the company, a listed issuer based in United Kingdom. Shares are quoted on UK GB, under the oversight of RNS (LSE). Market capitalisation: €1.1bn. The latest transaction was disclosed on 4 June 2026 (Purchase). Among the most active insiders: UNKNOWN. All data is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
BioPharma Credit PLC is an investment company focused on financing biopharmaceutical companies. It aims to provide capital to support the development of new treatments and medications.